AL
FCX icon

Aspiriant LLC’s Freeport-McMoran FCX Stock Holding History

Aspiriant LLC’s Portfolio FCX Stock Details FCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$249K Buy
+3,952
New +$254K 0.01% 347

Other funds holding FCX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Aspiriant LLC's FCX Position: Q2 2026 in Review

Aspiriant LLC opened a new position in Freeport-McMoran (FCX) in Q2 2026: 3,952 shares worth $249K. The stake represents 0.01% of the portfolio and ranks #347 among its holdings.

1,888 funds tracked by Wall St. Rank hold FCX as of Q2 2026.

  • Aspiriant LLC held 3,952 shares of Freeport-McMoran worth $249K as of Q2 2026.
  • Freeport-McMoran was a new Aspiriant LLC position in Q2 2026.
  • Freeport-McMoran made up 0.01% of Aspiriant LLC's portfolio in Q2 2026, its #347 holding.
  • 1,888 funds tracked by Wall St. Rank held Freeport-McMoran as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.